|
K562 single cells
|
97.15 μmol/L
|
Cell viability calculated based on calcein-AM/PI staining, followed by IC50 calculation with Origin Basic Functions: Logistic dose response in Pharmaceutical/Chemistry.
|
Download PDF
|
|
K562 cell-derived clones
|
90.03 μmol/L
|
Cell viability calculated based on calcein-AM/PI staining, followed by IC50 calculation with Origin Basic Functions: Logistic dose response in Pharmaceutical/Chemistry.
|
Download PDF
|
|
A375 cell line
|
256 µM (24h), 740 µM (6h)
|
Resarzurin assay, non-linear regression with GraphPad Prism
|
PMC12180162
|
|
W12 20861 cells
|
10 µM
|
MTT assay
|
Download PDF
|
|
W12 20822 cells
|
11.8 µM
|
MTT assay
|
Download PDF
|
|
W12 20850 cells
|
53.7 µM
|
MTT assay
|
Download PDF
|
|
W12 20862 cells
|
25 µM
|
MTT assay
|
Download PDF
|
|
W12 201402 cells
|
25 µM
|
MTT assay
|
Download PDF
|
|
MDA-MB-453
|
8.32 µM
|
MTT assay
|
Download PDF
|
|
MCF7
|
78 µM
|
MTT assay
|
Download PDF
|
|
MCF7/Her2-18
|
66 µM
|
MTT assay
|
Download PDF
|
|
BT474
|
18 µM
|
Alamar Blue assay
|
PMC9091702
|
|
HepG2 cells
|
19.67 μg/mL
|
CCK-8 detection kit
|
Download PDF
|
|
HeLa cells
|
614 nM
|
Dual-Luciferase assays (PEPCK-Luc reporter)
|
PMC6768326
|
|
HSMM
|
250 µM
|
IncuCyte Live-Cell Proliferation Analysis
|
Download PDF
|
|
hSCAPs
|
3380 mM (6 h), 1501 μM (12 h), 73.33 μM (24 h)
|
methylthiazolyldiphenyl-tetrazoliumbromide (MTT) assay
|
Download PDF
|
|
CSLCs
|
65.88 ± 1.57 µg/mL
|
MTT assay
|
Download PDF
|
|
Red Blood Cells
|
36 µM
|
BODIPY as a probe of lipid peroxidation
|
Download PDF
|
|
NCI-H1703
|
21.6 µM
|
sulforhodamine B (SRB) assay
|
Download PDF
|
|
NCI-H1581
|
31.9 µM
|
sulforhodamine B (SRB) assay
|
Download PDF
|
|
NCI-H358
|
39.8 µM
|
sulforhodamine B (SRB) assay
|
Download PDF
|
|
A549
|
43.9 µM
|
sulforhodamine B (SRB) assay
|
Download PDF
|
|
NCI-H1299
|
52.2 µM
|
sulforhodamine B (SRB) assay
|
Download PDF
|
|
HCC827
|
60.6 µM
|
sulforhodamine B (SRB) assay
|
Download PDF
|
|
A-427
|
60.8 µM
|
sulforhodamine B (SRB) assay
|
Download PDF
|
|
Calu-3
|
231.8 µM
|
sulforhodamine B (SRB) assay
|
Download PDF
|
|
MCF-7
|
67.6–82.2 µM
|
Antitumor Activity
|
Download PDF
|
|
ZR-75-1
|
67.6–82.2 µM
|
Antitumor Activity
|
Download PDF
|
|
MDA-MB-231
|
67.6–82.2 µM
|
Antitumor Activity
|
Download PDF
|
|
MCF-10A
|
20 µM
|
Antitumor Activity
|
Download PDF
|
|
Hepa1-6 cells
|
174.2 mM
|
Cell Counting Kit-8 (CCK-8) assay
|
Download PDF
|
|
SNU398 cells
|
167.7 mM
|
Cell Counting Kit-8 (CCK-8) assay
|
Download PDF
|
|
HepG2 cells
|
188.2 mM
|
Cell Counting Kit-8 (CCK-8) assay
|
Download PDF
|
|
A549 cells
|
91.77 µM (48 h), 71.71 µM (72 h)
|
MTT assay, Probit regression test
|
PMC7473753
|
|
HaCaT cells (human keratinocytes)
|
40.34 µM
|
Trypan Blue method
|
Download PDF
|
|
A549 cells
|
122 µM
|
acid phosphatase (AP) colorimetric assay
|
Download PDF
|
|
A549 cells
|
74 µM
|
acid phosphatase (AP) colorimetric assay
|
Download PDF
|
|
SW480
|
153.6 ± 10.65 µM
|
The colorimetric test with Sulforhodamine B (SRB) was used to evaluate cell viability.
|
Download PDF
|
|
SW480
|
123 ± 4.5 µM
|
The colorimetric test with Sulforhodamine B (SRB) was used to evaluate cell viability.
|
Download PDF
|
|
SW620
|
49.0 ± 38.5 µM
|
The colorimetric test with Sulforhodamine B (SRB) was used to evaluate cell viability.
|
Download PDF
|
|
SW620
|
143.1 ± 4.0 µM
|
The colorimetric test with Sulforhodamine B (SRB) was used to evaluate cell viability.
|
Download PDF
|
|
HaCaT
|
228.5 ± 18.25 µM
|
The colorimetric test with Sulforhodamine B (SRB) was used to evaluate cell viability.
|
Download PDF
|
|
HaCaT
|
20.2 ± 2.7 µM
|
The colorimetric test with Sulforhodamine B (SRB) was used to evaluate cell viability.
|
Download PDF
|
|
CHO-K1
|
118.4 ± 8.54 µM
|
The colorimetric test with Sulforhodamine B (SRB) was used to evaluate cell viability.
|
Download PDF
|
|
CHO-K1
|
64.0 ± 8.9 µM
|
The colorimetric test with Sulforhodamine B (SRB) was used to evaluate cell viability.
|
Download PDF
|
|
HeLa
|
96.67 µM
|
MTT assay
|
Download PDF
|
|
HeLa
|
65.85 µM
|
MTT assay
|
Download PDF
|
|
MCF-7
|
143.14 µM
|
MTT assay
|
Download PDF
|
|
MCF-7
|
100.16 µM
|
MTT assay
|
Download PDF
|
|
MRC-5
|
135.01 µM
|
MTT assay
|
Download PDF
|
|
MRC-5
|
109.76 µM
|
MTT assay
|
Download PDF
|
|
HeLa cells
|
64.6 mM
|
WST-1 assays
|
Download PDF
|
|
A549 lung cancer cells
|
8.43 µg/mL
|
MTT assay
|
PMC6333390
|
|
MEF adipocytes
|
9.37 µM
|
Oil Red O staining and spectrophotometric measurement
|
Download PDF
|
|
MCF10CA1a
|
15 µM
|
Trypan blue exclusion test
|
Download PDF
|
|
MCF-7
|
15 µM
|
Trypan blue exclusion test
|
Download PDF
|
|
MCF10CA1a
|
21–22 µM
|
Trypan blue exclusion test
|
Download PDF
|
|
MCF-7
|
21–22 µM
|
Trypan blue exclusion test
|
Download PDF
|
|
SKOV-3
|
88.35 µM
|
MTT assay
|
Download PDF
|
|
SKOV-3
|
22.00 µM
|
MTT assay
|
Download PDF
|
|
MDAH-2774
|
13.22 µM
|
MTT assay
|
Download PDF
|
|
MDAH-2774
|
18.99 µM
|
MTT assay
|
Download PDF
|
|
A549 cells
|
118.1 μM
|
CCK-8 assay
|
Download PDF
|
|
ES-2
|
74.32 µM
|
alamarBlue assay, dose-dependent response curves
|
Download PDF
|
|
A549 cells
|
14.7 µmol/L
|
MTT method
|
PMC9975635
|
|
CT26 cells
|
88.76 ± 1.07 μM
|
WST1 assay
|
Download PDF
|
|
U251 cells
|
108.9 µM
|
CCK-8 assay
|
Download PDF
|
|
LN428 cells
|
441.3 µM
|
CCK-8 assay
|
Download PDF
|
|
B. bovis
|
29.51 ± 2.46 µM
|
SGI-based fluorescence assay
|
Download PDF
|
|
B. bigemina
|
56.25 ± 8.83 µM
|
SGI-based fluorescence assay
|
Download PDF
|
|
B. divergens
|
148.67 ± 5.88 µM
|
SGI-based fluorescence assay
|
Download PDF
|
|
T. equi
|
53.57 ± 5.04 µM
|
SGI-based fluorescence assay
|
Download PDF
|
|
B. caballi
|
185.75 ± 2.74 µM
|
SGI-based fluorescence assay
|
Download PDF
|
|
A2780
|
48µM (MTT), 65µM (LDH)
|
MTT test and LDH release assay
|
Download PDF
|
|
OVCAR-3
|
480µM (MTT), 525µM (LDH)
|
MTT test and LDH release assay
|
Download PDF
|
|
SKOV-3
|
380µM (MTT), 346µM (LDH)
|
MTT test and LDH release assay
|
Download PDF
|
|
HOSE cells
|
485µM (MTT), 421µM (LDH)
|
MTT test and LDH release assay
|
Download PDF
|
|
HPMCs
|
465µM (MTT), 495µM (LDH)
|
MTT test and LDH release assay
|
Download PDF
|
|
MCF-7 cells
|
137.58 μg/mL
|
CCK-8 assay
|
PMC5373843
|
|
U87 cells
|
8.33 μg/mL
|
XTT assay
|
PMC5179207
|
|
Uropathogenic Escherichia coli
|
500 µg/mL
|
Standard BMD (Broth Microdilution Method)
|
Download PDF
|
|
HCT-116
|
34.03 ± 2.45 μg/mL
|
MTT (3-[4, 5-dimethylthiazol-2-yl]-2, 5) diphenyl tetrazolium bromide) cell proliferation assay
|
Download PDF
|
|
WI-38
|
85.87 ± 2.74 μg/mL
|
MTT (3-[4, 5-dimethylthiazol-2-yl]-2, 5) diphenyl tetrazolium bromide) cell proliferation assay
|
Download PDF
|
|
L. major promastigotes
|
16.23 µg/mL
|
Vital staining (0.1% eosin stain) and counting with a light microscope, followed by nonlinear least-squares regression analysis.
|
Download PDF
|
|
THP-1 cells
|
20.17 µg
|
MTT assay, Concentration-effect curve
|
PMC11539838
|
|
THP-1 cells
|
55.38 µg
|
MTT assay, Concentration-effect curve
|
PMC11539838
|
|
SKOV3 cells
|
93.2 µM (at 72 h)
|
CCK-8 assay
|
Download PDF
|
|
Growing Caco-2 cells
|
156 μM
|
Microplate colorimetric assay (MTT assay)
|
Download PDF
|
|
Differentiated Caco-2 cells
|
373 μM
|
Microplate colorimetric assay (MTT assay)
|
Download PDF
|
|
NK-92 cells
|
154.00 μM (24h), 75.44 μM (48h), 65.21 μM (72h)
|
CCK-8 assay
|
PMC7327334
|
|
3T3-L1 adipocytes
|
48.05 μM
|
MTT assay
|
Download PDF
|
|
hDPSCs
|
67.65 ± 9.86
|
Cell viability assay
|
Download PDF
|
|
rabbit ventricular myocytes
|
34.442 mM
|
Whole-cell patch-clamp techniques to record INa.L, analyzed using clampfit 9.0 and PulseFit, with amplitudes tested at 200 ms in depolarization testing pulse.
|
Download PDF
|
|
rabbit ventricular myocytes
|
26.192 mM
|
Whole-cell patch-clamp techniques to record INa.L, analyzed using clampfit 9.0 and PulseFit, with amplitudes tested at 200 ms in depolarization testing pulse.
|
Download PDF
|
|
A375
|
25.5 mmol/L
|
Sulphorhodamine B Toxicology Assay Kit
|
Download PDF
|
|
A549
|
36.2 mmol/L
|
Sulphorhodamine B Toxicology Assay Kit
|
Download PDF
|
|
HT29
|
71.9 mmol/L
|
Sulphorhodamine B Toxicology Assay Kit
|
Download PDF
|
|
MCF7
|
56.6 mmol/L
|
Sulphorhodamine B Toxicology Assay Kit
|
Download PDF
|
|
A431 cells
|
86.50 μM
|
MTT assay
|
Download PDF
|
|
CRBH7919 cells
|
< 40 μM
|
CCK8 assay
|
PMC6343688
|
|
Xanthomonas oryzae pv. oryzae
|
11.67 ± 0.58 μg/mL
|
Antibacterial activity was analyzed at 600 nm by a spectrophotometer after 18 h incubation, and IC50 values were obtained by interpolation from linear regression analysis.
|
Download PDF
|
|
RAW 264.7 macrophages
|
6.8 ± 0.6 mM
|
oxidation-sensitive 2,4 dichlorodihydrofluorescein-diacetate (C-400) fluorescent dye
|
Download PDF
|
|
Y79
|
80 mM
|
Alamar Blue-based viability assay
|
Download PDF
|
|
RB355
|
80 mM
|
Alamar Blue-based viability assay
|
Download PDF
|
|
K562 single cells
|
97.15 μmol/L
|
Cell viability calculated based on calcein-AM/PI staining, followed by IC50 calculation with Origin Basic Functions: Logistic dose response in Pharmaceutical/Chemistry.
|
Download PDF
|
|
K562 cell-derived clones
|
90.03 μmol/L
|
Cell viability calculated based on calcein-AM/PI staining, followed by IC50 calculation with Origin Basic Functions: Logistic dose response in Pharmaceutical/Chemistry.
|
Download PDF
|
|
A375 cell line
|
256 µM (24h), 740 µM (6h)
|
Resarzurin assay, non-linear regression with GraphPad Prism
|
PMC12180162
|
|
W12 20861 cells
|
10 µM
|
MTT assay
|
Download PDF
|
|
W12 20822 cells
|
11.8 µM
|
MTT assay
|
Download PDF
|
|
W12 20850 cells
|
53.7 µM
|
MTT assay
|
Download PDF
|
|
W12 20862 cells
|
25 µM
|
MTT assay
|
Download PDF
|
|
W12 201402 cells
|
25 µM
|
MTT assay
|
Download PDF
|
|
MDA-MB-453
|
8.32 µM
|
MTT assay
|
Download PDF
|
|
MCF7
|
78 µM
|
MTT assay
|
Download PDF
|
|
MCF7/Her2-18
|
66 µM
|
MTT assay
|
Download PDF
|
|
BT474
|
18 µM
|
Alamar Blue assay
|
PMC9091702
|
|
HepG2 cells
|
19.67 μg/mL
|
CCK-8 detection kit
|
Download PDF
|
|
HeLa cells
|
614 nM
|
Dual-Luciferase assays (PEPCK-Luc reporter)
|
PMC6768326
|
|
HSMM
|
250 µM
|
IncuCyte Live-Cell Proliferation Analysis
|
Download PDF
|
|
hSCAPs
|
3380 mM (6 h), 1501 μM (12 h), 73.33 μM (24 h)
|
methylthiazolyldiphenyl-tetrazoliumbromide (MTT) assay
|
Download PDF
|
|
CSLCs
|
65.88 ± 1.57 µg/mL
|
MTT assay
|
Download PDF
|
|
Red Blood Cells
|
36 µM
|
BODIPY as a probe of lipid peroxidation
|
Download PDF
|
|
NCI-H1703
|
21.6 µM
|
sulforhodamine B (SRB) assay
|
Download PDF
|
|
NCI-H1581
|
31.9 µM
|
sulforhodamine B (SRB) assay
|
Download PDF
|
|
NCI-H358
|
39.8 µM
|
sulforhodamine B (SRB) assay
|
Download PDF
|
|
A549
|
43.9 µM
|
sulforhodamine B (SRB) assay
|
Download PDF
|
|
NCI-H1299
|
52.2 µM
|
sulforhodamine B (SRB) assay
|
Download PDF
|
|
HCC827
|
60.6 µM
|
sulforhodamine B (SRB) assay
|
Download PDF
|
|
A-427
|
60.8 µM
|
sulforhodamine B (SRB) assay
|
Download PDF
|
|
Calu-3
|
231.8 µM
|
sulforhodamine B (SRB) assay
|
Download PDF
|
|
MCF-7
|
67.6–82.2 µM
|
Antitumor Activity
|
Download PDF
|
|
ZR-75-1
|
67.6–82.2 µM
|
Antitumor Activity
|
Download PDF
|
|
MDA-MB-231
|
67.6–82.2 µM
|
Antitumor Activity
|
Download PDF
|
|
MCF-10A
|
20 µM
|
Antitumor Activity
|
Download PDF
|
|
Hepa1-6 cells
|
174.2 mM
|
Cell Counting Kit-8 (CCK-8) assay
|
Download PDF
|
|
SNU398 cells
|
167.7 mM
|
Cell Counting Kit-8 (CCK-8) assay
|
Download PDF
|
|
HepG2 cells
|
188.2 mM
|
Cell Counting Kit-8 (CCK-8) assay
|
Download PDF
|
|
A549 cells
|
91.77 µM (48 h), 71.71 µM (72 h)
|
MTT assay, Probit regression test
|
PMC7473753
|
|
HaCaT cells (human keratinocytes)
|
40.34 µM
|
Trypan Blue method
|
Download PDF
|
|
A549 cells
|
122 µM
|
acid phosphatase (AP) colorimetric assay
|
Download PDF
|
|
A549 cells
|
74 µM
|
acid phosphatase (AP) colorimetric assay
|
Download PDF
|
|
SW480
|
153.6 ± 10.65 µM
|
The colorimetric test with Sulforhodamine B (SRB) was used to evaluate cell viability.
|
Download PDF
|
|
SW480
|
123 ± 4.5 µM
|
The colorimetric test with Sulforhodamine B (SRB) was used to evaluate cell viability.
|
Download PDF
|
|
SW620
|
49.0 ± 38.5 µM
|
The colorimetric test with Sulforhodamine B (SRB) was used to evaluate cell viability.
|
Download PDF
|
|
SW620
|
143.1 ± 4.0 µM
|
The colorimetric test with Sulforhodamine B (SRB) was used to evaluate cell viability.
|
Download PDF
|
|
HaCaT
|
228.5 ± 18.25 µM
|
The colorimetric test with Sulforhodamine B (SRB) was used to evaluate cell viability.
|
Download PDF
|
|
HaCaT
|
20.2 ± 2.7 µM
|
The colorimetric test with Sulforhodamine B (SRB) was used to evaluate cell viability.
|
Download PDF
|
|
CHO-K1
|
118.4 ± 8.54 µM
|
The colorimetric test with Sulforhodamine B (SRB) was used to evaluate cell viability.
|
Download PDF
|
|
CHO-K1
|
64.0 ± 8.9 µM
|
The colorimetric test with Sulforhodamine B (SRB) was used to evaluate cell viability.
|
Download PDF
|
|
HeLa
|
96.67 µM
|
MTT assay
|
Download PDF
|
|
HeLa
|
65.85 µM
|
MTT assay
|
Download PDF
|
|
MCF-7
|
143.14 µM
|
MTT assay
|
Download PDF
|
|
MCF-7
|
100.16 µM
|
MTT assay
|
Download PDF
|
|
MRC-5
|
135.01 µM
|
MTT assay
|
Download PDF
|
|
MRC-5
|
109.76 µM
|
MTT assay
|
Download PDF
|
|
HeLa cells
|
64.6 mM
|
WST-1 assays
|
Download PDF
|
|
A549 lung cancer cells
|
8.43 µg/mL
|
MTT assay
|
PMC6333390
|
|
MEF adipocytes
|
9.37 µM
|
Oil Red O staining and spectrophotometric measurement
|
Download PDF
|
|
MCF10CA1a
|
15 µM
|
Trypan blue exclusion test
|
Download PDF
|
|
MCF-7
|
15 µM
|
Trypan blue exclusion test
|
Download PDF
|
|
MCF10CA1a
|
21–22 µM
|
Trypan blue exclusion test
|
Download PDF
|
|
MCF-7
|
21–22 µM
|
Trypan blue exclusion test
|
Download PDF
|
|
SKOV-3
|
88.35 µM
|
MTT assay
|
Download PDF
|
|
SKOV-3
|
22.00 µM
|
MTT assay
|
Download PDF
|
|
MDAH-2774
|
13.22 µM
|
MTT assay
|
Download PDF
|
|
MDAH-2774
|
18.99 µM
|
MTT assay
|
Download PDF
|
|
A549 cells
|
118.1 μM
|
CCK-8 assay
|
Download PDF
|
|
ES-2
|
74.32 µM
|
alamarBlue assay, dose-dependent response curves
|
Download PDF
|
|
A549 cells
|
14.7 µmol/L
|
MTT method
|
PMC9975635
|
|
CT26 cells
|
88.76 ± 1.07 μM
|
WST1 assay
|
Download PDF
|
|
U251 cells
|
108.9 µM
|
CCK-8 assay
|
Download PDF
|
|
LN428 cells
|
441.3 µM
|
CCK-8 assay
|
Download PDF
|
|
B. bovis
|
29.51 ± 2.46 µM
|
SGI-based fluorescence assay
|
Download PDF
|
|
B. bigemina
|
56.25 ± 8.83 µM
|
SGI-based fluorescence assay
|
Download PDF
|
|
B. divergens
|
148.67 ± 5.88 µM
|
SGI-based fluorescence assay
|
Download PDF
|
|
T. equi
|
53.57 ± 5.04 µM
|
SGI-based fluorescence assay
|
Download PDF
|
|
B. caballi
|
185.75 ± 2.74 µM
|
SGI-based fluorescence assay
|
Download PDF
|
|
A2780
|
48µM (MTT), 65µM (LDH)
|
MTT test and LDH release assay
|
Download PDF
|
|
OVCAR-3
|
480µM (MTT), 525µM (LDH)
|
MTT test and LDH release assay
|
Download PDF
|
|
SKOV-3
|
380µM (MTT), 346µM (LDH)
|
MTT test and LDH release assay
|
Download PDF
|
|
HOSE cells
|
485µM (MTT), 421µM (LDH)
|
MTT test and LDH release assay
|
Download PDF
|
|
HPMCs
|
465µM (MTT), 495µM (LDH)
|
MTT test and LDH release assay
|
Download PDF
|
|
MCF-7 cells
|
137.58 μg/mL
|
CCK-8 assay
|
PMC5373843
|
|
U87 cells
|
8.33 μg/mL
|
XTT assay
|
PMC5179207
|
|
Uropathogenic Escherichia coli
|
500 µg/mL
|
Standard BMD (Broth Microdilution Method)
|
Download PDF
|
|
HCT-116
|
34.03 ± 2.45 μg/mL
|
MTT (3-[4, 5-dimethylthiazol-2-yl]-2, 5) diphenyl tetrazolium bromide) cell proliferation assay
|
Download PDF
|
|
WI-38
|
85.87 ± 2.74 μg/mL
|
MTT (3-[4, 5-dimethylthiazol-2-yl]-2, 5) diphenyl tetrazolium bromide) cell proliferation assay
|
Download PDF
|
|
L. major promastigotes
|
16.23 µg/mL
|
Vital staining (0.1% eosin stain) and counting with a light microscope, followed by nonlinear least-squares regression analysis.
|
Download PDF
|
|
THP-1 cells
|
20.17 µg
|
MTT assay, Concentration-effect curve
|
PMC11539838
|
|
THP-1 cells
|
55.38 µg
|
MTT assay, Concentration-effect curve
|
PMC11539838
|
|
SKOV3 cells
|
93.2 µM (at 72 h)
|
CCK-8 assay
|
Download PDF
|
|
Growing Caco-2 cells
|
156 μM
|
Microplate colorimetric assay (MTT assay)
|
Download PDF
|
|
Differentiated Caco-2 cells
|
373 μM
|
Microplate colorimetric assay (MTT assay)
|
Download PDF
|
|
NK-92 cells
|
154.00 μM (24h), 75.44 μM (48h), 65.21 μM (72h)
|
CCK-8 assay
|
PMC7327334
|
|
3T3-L1 adipocytes
|
48.05 μM
|
MTT assay
|
Download PDF
|
|
hDPSCs
|
67.65 ± 9.86
|
Cell viability assay
|
Download PDF
|
|
rabbit ventricular myocytes
|
34.442 mM
|
Whole-cell patch-clamp techniques to record INa.L, analyzed using clampfit 9.0 and PulseFit, with amplitudes tested at 200 ms in depolarization testing pulse.
|
Download PDF
|
|
rabbit ventricular myocytes
|
26.192 mM
|
Whole-cell patch-clamp techniques to record INa.L, analyzed using clampfit 9.0 and PulseFit, with amplitudes tested at 200 ms in depolarization testing pulse.
|
Download PDF
|
|
A375
|
25.5 mmol/L
|
Sulphorhodamine B Toxicology Assay Kit
|
Download PDF
|
|
A549
|
36.2 mmol/L
|
Sulphorhodamine B Toxicology Assay Kit
|
Download PDF
|
|
HT29
|
71.9 mmol/L
|
Sulphorhodamine B Toxicology Assay Kit
|
Download PDF
|
|
MCF7
|
56.6 mmol/L
|
Sulphorhodamine B Toxicology Assay Kit
|
Download PDF
|
|
A431 cells
|
86.50 μM
|
MTT assay
|
Download PDF
|
|
CRBH7919 cells
|
< 40 μM
|
CCK8 assay
|
PMC6343688
|
|
Xanthomonas oryzae pv. oryzae
|
11.67 ± 0.58 μg/mL
|
Antibacterial activity was analyzed at 600 nm by a spectrophotometer after 18 h incubation, and IC50 values were obtained by interpolation from linear regression analysis.
|
Download PDF
|
|
RAW 264.7 macrophages
|
6.8 ± 0.6 mM
|
oxidation-sensitive 2,4 dichlorodihydrofluorescein-diacetate (C-400) fluorescent dye
|
Download PDF
|
|
Y79
|
80 mM
|
Alamar Blue-based viability assay
|
Download PDF
|
|
RB355
|
80 mM
|
Alamar Blue-based viability assay
|
Download PDF
|